AlbertLaiMDPhD
Neurology • Los Angeles, CANeurooncology
Assistant Professor, Neurology, UCLA School of Medicine
Are you Dr. Lai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 83 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Medical Plz
Suite B200
Los Angeles, CA 90095Phone+1 310-794-1195Fax+1 310-794-7491- Is this information wrong?
Summary
- Dr. Albert Lai, MD is a board certified neurologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Ronald Reagan UCLA Medical Center, UCLA Medical Center-Santa Monica, and Providence St. Jude Medical Center.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2002 - 2005- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1999 - 2002
Adventist Health White MemorialInternship, Internal Medicine, 1998 - 1999
University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2011 Oct 03
- Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation.Sean T Pianka, Tie Li, Terry J Prins, Blaine S C Eldred, Bryan M Kevan, Haowen Liang, Serendipity Zapanta Rinonos, Harley I Kornblum, David A Nathanson, Matteo Pellegr...> ;Cancer Research Communications. 2024 Mar 22
- Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction.Cho, N., Sanvito, F., Le, V., Oshima, S., Teraishi, A., Yao, J., Telesca, D., Raymond, C., Pope, W., Ellingson, B., Nghiemphu, P., Lai, A., Cloughesy, T., Salamon, N.> ;AJNR. American Journal of Neuroradiology. 2024 Feb 7
- dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.Serendipity Zapanta Rinonos, Tie Li, Sean Thomas Pianka, Terry J Prins, Blaine S C Eldred, Bryan M Kevan, Linda M Liau, Phioanh Leia Nghiemphu, Timothy F Cloughesy, Al...> ;Journal of Neuro-Oncology. 2024 Jan 1
- Join now to see all
Press Mentions
- Preferential Tumor Localization in Relation to 18F-FDOPA Uptake for Lower‐Grade GliomasMarch 11th, 2021
Relative Oxygen Extraction Fraction (rOEF) MR Imaging Reveals Higher Hypoxia in Human Epidermal Growth Factor Receptor (EGFR) Amplified Compared with Non-Amplified GliomasOctober 26th, 2020
Impact of Dementia Risk Factors May Vary by Race and Ethnicity, Study FindsOctober 19th, 2023
Hospital Affiliations
- Placentia-Linda HospitalPlacentia, California
Ronald Reagan UCLA Medical CenterLos Angeles, California
Providence St. Jude Medical CenterFullerton, California- UCLA Medical Center-Santa MonicaSanta Monica, California
